Go Pro
NASDAQ:BKYI

BIO-key International (BKYI) Stock Price, News & Analysis

BIO-key International logo
$2.47 -0.01 (-0.40%)
Closing price 09/21/2026 03:59 PM Eastern
Extended Trading
$2.58 +0.11 (+4.45%)
As of 08:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About BIO-key International Stock (NASDAQ:BKYI)

Advanced

Key Stats

Today's Range
$2.47
$2.66
50-Day Range
$2.47
$5.00
52-Week Range
$2.40
$19.70
Volume
13,572 shs
Average Volume
18,334 shs
Market Capitalization
$3.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

BIO-key International, Inc. develops biometric identity and access management solutions designed to help organizations secure applications, devices and networks. Its offerings use fingerprint authentication and other authentication methods to provide alternatives or supplements to passwords, supporting secure access for employees, students, customers and other users.

The company’s products include biometric readers and related software, as well as its PortalGuard identity and access management platform. PortalGuard provides capabilities such as single sign-on, multifactor authentication, self-service password management and identity verification. BIO-key’s solutions can be deployed in cloud, on-premises or hybrid environments and are intended for use with enterprise, education, healthcare, government and other organizational systems.

BIO-key was founded in 1993 and is headquartered in Wall, New Jersey. The company markets its products directly and through partners to organizations in the United States and international markets. Michael DePasquale serves as the company’s chairman and chief executive officer.

AI Generated. May Contain Errors.

BIO-key International Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

BKYI MarketRank™: 

BIO-key International scored higher than 26% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    BIO-key International has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    BIO-key International has only been the subject of 2 research reports in the past 90 days.

  • Read more about BIO-key International's stock forecast and price target.
  • Earnings Growth

    Earnings for BIO-key International are expected to grow in the coming year, from ($1.62) to $0.22 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BIO-key International is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BIO-key International is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    BIO-key International has a P/B Ratio of 0.52. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about BIO-key International's valuation and earnings.
  • Percentage of Shares Shorted

    0.79% of the float of BIO-key International has been sold short.
  • Short Interest Ratio / Days to Cover

    BIO-key International has a short interest ratio ("days to cover") of 0.34, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in BIO-key International has recently decreased by 20.89%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    BIO-key International does not currently pay a dividend.

  • Dividend Growth

    BIO-key International does not have a long track record of dividend growth.

  • News Sentiment

    BIO-key International has a news sentiment score of -0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for BIO-key International this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, BIO-key International insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    4.00% of the stock of BIO-key International is held by insiders.

  • Percentage Held by Institutions

    26.51% of the stock of BIO-key International is held by institutions.

  • Read more about BIO-key International's insider trading history.
Receive BKYI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BKYI Stock News Headlines

BIO-key International, Inc.(NasdaqCM:BKYI) added to S&P TMI Index
China's dominance in rare earth processing sparks new defense rules
On January 1, 2027, new Pentagon rules tighten sourcing restrictions on critical minerals tied to foreign adversaries. China controls more than 90% of global rare earth processing capacity, while the U.S. imports 100% of its titanium sponge. SAGA Metals has drilled more than 23,000 meters at its Radar project, with all 92 drill holes intersecting mineralization. A maiden mineral resource estimate is expected in Q4 2026, alongside ongoing drilling at the Wolverine heavy rare earth project.tc pixel
See More Headlines

BKYI Stock Analysis - Frequently Asked Questions

BIO-key International's stock was trading at $5.3910 at the beginning of the year. Since then, BKYI stock has decreased by 54.2% and is now trading at $2.47.

BIO-key International Inc. (NASDAQ:BKYI) posted its quarterly earnings results on Thursday, August, 13th. The technology company reported ($0.56) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.82) by $0.26. The technology company had revenue of $1.92 million for the quarter, compared to the consensus estimate of $1.80 million. BIO-key International had a negative trailing twelve-month return on equity of 67.31% and a negative net margin of 50.01%.
Read the conference call transcript
.

BIO-key International shares reverse split on Thursday, December 21st 2023.The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BIO-key International investors own include ExxonMobil (XOM), T2 Biosystems (TTOO), Nokia (NOK), Tonix Pharmaceuticals (TNXP) and

Company Calendar

Last Earnings
8/13/2026
Today
9/21/2026
Next Earnings (Estimated)
11/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Software
Sub-Industry
Systems Software
Current Symbol
NASDAQ:BKYI
CIK
1019034
Employees
42
Year Founded
1993

Profitability

EPS (Trailing Twelve Months)
($4.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.16 million
Net Margins
-50.01%
Pretax Margin
-87.79%
Return on Equity
-67.31%
Return on Assets
-40.28%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.26
Quick Ratio
1.14

Sales & Book Value

Annual Sales
$6.09 million
Price / Sales
0.58
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.71 per share
Price / Book
0.52

Miscellaneous

Outstanding Shares
1,440,000
Free Float
1,379,000
Market Cap
$3.56 million
Optionable
No Data
Beta
0.40

Social Links

10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:BKYI) was last updated on 9/22/2026 by MarketBeat.com Staff.
From Our Partners